Clinical practice guidelines on the initial assessment and treatment of urinary incontinence in women: A US focused review

International Journal of Gynecology and Obstetrics

Volumn 86, Issue SUPPL., 2004, Pages

  Viktrup, Lars ^a   Summers, Kent H ^b   Dennett, Susan L ^c  

^a ELI LILLY AND COMPANY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Strategic Health Outcomes   (United States)

Author keywords

Practice guidelines; Review; Urinary incontinence

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DULOXETINE; ESTROGEN; GESTAGEN; IMIPRAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; PHENYLPROPANOLAMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE; HEALTH CARE ORGANIZATION; HUMAN; MEDICAL LITERATURE; MIXED INCONTINENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STRESS INCONTINENCE; UNITED STATES; URGE INCONTINENCE; URINE INCONTINENCE; WORLD HEALTH ORGANIZATION;

EID: 4043089860     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2004.05.008     Document Type: Article

References (58)

1. National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases. Overcoming Bladder Disease. A Strategic Plan for Research. Urinary Incontinence: Common Clinical Conditions. A report of the bladder research progress review group. 2002. Accessed October 13, 2003 at http://www.niddk.nih.gov/fund/other/brprg_book.pdf
2. Diokno A.C., Burgio K., Fultz N.H., Kinchen K., Obenchain R., Bump R. Medical and self-care practices reported by women experiencing urinary incontinence. Am J Managed Care. 10:(part 1):2004;69-78
3. Hunskaar S., Lose G., Sykes D., Voss S. The prevalence of urinary incontinence in women in four European countries. Br J Urol Int. 93:2004;324-330
4. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., et al. The standardisation of terminology in lower urinary tract function: Report from the standardisation subcommittee of the international continence society. Urology. 62:2003;37-49
5. Nihira M.A., Henderson N. Epidemiology of urinary incontinence in women. Curr Womens Health Rep. 3:(4):2003;340-347
6. Fultz N.H., Burgio K., Diokono A.C., Kinchen K.S., Obenchain R., Bump R.C. Burden of stress urinary incontinence for community-dwelling women. Am J Obstet Gynecol. 189:(5):2003;1275-1282
7. Wilson L., Brown J.S., Shin G.P., Luc K., Subak L.L. Annual direct cost of urinary incontinence. Obstet Gynecol. 98:2001;398-406
8. Kinchen K.S., Long S., Orsini L., Crown W., Swindle R. A retrospective claims analysis of the direct costs of stress urinary incontinence. Int Urogynecol J. 14:2003;403-411
9. Voss S, Lose G, Papanicolaou S, Sykes D, Hunskaar S: How bothersome is urinary incontinence? Results from a study of women in four European countries. Abstract presented at the XIXth Congress of the European Association of Urology, March 24-27, 2004 in Vienna, Austria
10. McFall S., Yerkes A.M., Bernard M., LeRud T. Evaluation and treatment of urinary incontinence. Report of a physician survey. Arch Fam Med. 6:1997;114-119
11. Hullfish K.L., Bovbjerg V.E. Medical student exposure to female pelvic floor dysfunction: A survey of new house staff. J Pelvic Med & Surg. 9:2003;37-40
12. Gordon D., Groutz A. Evaluation of female lower urinary tract symptoms: Overview and update. Curr Opin Obstet Gynecol. 13:2001;521-527
13. Viktrup L, Bump RC: Assessment of female urinary incontinence in the ob/gyn office. Contemporary OB/GYN 2004 (in press)
14. Jancin B. Family physicians can treat most cases of urinary incontinence. Fam Pract News. 31:2001;18
15. Seim A., Hermstad R., Hunskaar S. Female urinary incontinence: long-term follow-up after treatment in general practice. Br J Gen Pract. 48:1998;1727-1728
16. Diokno A.C., Dimaculangan R.R., Lim E.J., Steinert B.W. Office based criteria for predicting type II stress incontinence without further evaluation studies. J Urol. 161:1999;1263-1267
17. Abrams P, Cardozo L, Khoury S, Wein A (Eds.), Incontinence. 2nd International Consultation on Incontinence, 2nd edn. Plymouth (UK): Plymbridge Distributors, Ltd. 2002. Also, available at http://www.continet.org/documents/ ici_pdfs/menus/main.pdf
18. Duncan P.W., Horner R.D., Reker D.M., Samsa G.P., Hoenig H., Hamilton B., et al. Adherence to postacute rehabilitation guidelines is associated with functional recovery in stroke. Stroke. 33:2002;167-178
19. Lucarelli C.D. Formulary management strategies for type 3 serotonin receptor antagonists. Am J Health Syst Pharm. 60:(10 suppl. 1):2003;S4-S11
20. Szekendi M.K. American College of Cardiology, American Heart Association: Compliance with acute MI guidelines lowers inpatient mortality. J Cardiovasc Nurs. 18:(5):2003;356-359
21. Frantz R.A., Xakellis G.C., Harvey P.C., Lewis A.R. Implementing an incontinence management protocol in long-term care. Clinical outcomes and costs. J Gerontol Nurs. 29:2003;46-53
22. Viktrup L., Summers K.H., Dennett S.L. Clinical practice guidelines for initial management of urinary incontinence in women: An European-focused review. BJU Int. 94:(Suppl 1):2004;14-22
23. Agency for Healthcare Research and Quality (AHRQ) National Guideline Clearinghouse. Accessed on January 22, 2004 at http://www.guideline.gov/
24. Fantl JA, Newman DK, Colling J. Urinary Incontinence in Adults: Acute and Chronic Management. Clinical Practice Guideline No. 2, 1996 Update. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 96-0682. March 1996
25. Agency for Healthcare Research and Quality (AHRQ): Reauthorization Fact Sheet. AHRQ Publication No. 00-P002, December 1999. Rockville, MD: Agency for Healthcare Research and Quality. Accessed January 22, 2004 at http://www.ahrq.gov/about/ahrqfact.htm
26. Agency for Healthcare Research and Quality (AHRQ): Frequently Asked Questions. July 2003. Rockville, MD: Agency for Healthcare Research and Quality. Accessed January 22, 2004 at http://www.ahrq.gov/faq.htm#guidelines
27. American Academy of Family Physicians (AAFP): Urinary incontinence: Assessment and management in family practice. 2002. Accessed January 14, 2004 at http://www.aafp.org/PreBuilt/videocme/urinary_mono.pdf
28. American Urological Association Female Stress Urinary Incontinence Clinical Guidelines Panel: The surgical management of female stress urinary incontinence. Clinical practice guidelines. 1997. Accessed September 4, 2003 at http://shop.auanet.org/timssnet/products/clinical_guidelines/FSUIptguide.pdf
29. American Medical Directors Association (AMDA): Urinary incontinence. Columbia, MD: American Medical Directors Association; 1996. 16 pp. Accessed July 21, 2003 at http://www.guideline.gov/summary/summary.aspx?doc_id=1812&nbr= 1038&string=incontinence.
30. American College of Obstetrics and Gynecology (ACOG): ACOG criteria set. Surgery for genuine stress incontinence due to urethral hypermobility. Int J Gynaecol Obstet 1996; 52: 211-212
31. Donovan J., Badia X., Corcos J., Goton M., Kelleher C., Naughton M., et al. Symptom and quality of life assessment. Abrams P., Cardozo L., Khoury S., Wein A. Incontinence. Second ed:2002;267-316 Health Publication Ltd, Plymouth, UK
32. Norton P.A., Zinner N.R., alcin I., Bump R.C. Duloxetine vs. placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol. 187:2002;40-48
33. Dmochowski R.R., Miklos J.R., Norton P.A., Zinner N.R., Yalcin I., Bump R.C. (Duloxetine Urinary Incontinence Study Group) Duloxetine vs. placebo for the treatment of North American women with stress urinary incontinence. J Urol. 170:(4 Pt 1):Oct., 2003;1259-1263
34. Stephenson J. FDA orders estrogen safety warnings: Agency offers guidance for HRT use. J Am Med Assoc. 289:(5):Feb 2003;537-538
35. US Food and Drug Administration: FDA News 2004; P04-18. Accessed February 10, 2004 at http://www.fda.gov/bbs/topics/NEWS/2004/NEW01022.html
36. Kernan W.N., Viscoli C.M., Brass L.M., Broderick J.P., Brott T., Feldmann E., et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 343:2000;1826-1832
37. Flemming G.A. The FDA, regulation and the risk of stroke (editorial). N Engl J Med. 343:2000;1886-1887
38. Andrews J.O., Tingen M.S., Waller J.L., Harper R.J. Provider feedback improves adherence with AHCPR smoking cessation guideline. Prev Med. 33:(5):2001;415-421
39. Albakri E.A., Richards F. 3rd, Hall M., Miranda L.S., Turkel R., Sand C., et al. Cooperative efforts to improve compliance with acute stroke guidelines. South Med J. 96:(1):2003;23-26
40. Kirkman M.S., Williams S.R., Caffrey H.H., Marrero D.G. Impact of a program to improve adherence to diabetes guidelines by primary care physicians. Diabetes Care. 25:(11):2002;1946-1951
41. Tierney W.M., Overhage M., Murray M.D., Harris L.E., Zhou X., Eckert G.J., et al. Effects of computerized guidelines for managing heart disease in primary care. J Gen Intern Med. 18:(12):2004;967-976
42. Hesdorffer D.C., Ghajar J., Iacono L. Predictors of compliance with the evidence-based guidelines for traumatic brain injury care: A survey of United States trauma centers. J Trauma. 52:(6):2002;1202-1209
43. Antguaco T.L., Oprescu F.G., Lal S.K., Pennington J.H., Russel B.D., Co J.M., et al. Universal precautions guideline: self-reported compliance by gastroenterologists and gastrointestinal endoscopy nurses - a decades lack of progress. Am Gastroenterol. 98:(11):2003;2420-2423
44. Clause S.L., Hamilton R.A. Medicaid prescriber compliance with Joint National Committee VI hypertension treatment guidelines. Ann Pharmacother. 36:(10):2002;1505-1511
45. Bland D.R., Dugan E., Cohen S.J., Preisser J., Davis C.C., McGann P.E., et al. The effects of implementation of the agency for health care policy and research urinary incontinence guidelines in primary care practices. J Am Geriatr Soc. 51:2003;979-984
46. Viktrup L, Moller LA. The handling of urinary incontinence in Danish general practices after distribution of guidelines and voiding diary reimbursement. BMC;2004 (in press)
47. Mason J., Freemantle N., Browning G. Impact of Effective Health Care bulletin on treatment of persistent glue ear in children: time series analysis. BMJ. 323:2001;1096-1097
48. Leape L.L., Weissman J.S., Schneider E.C., Piana R.N., Gatsonis C., Epstein A.M. Adherence to practice guidelines: The role of specialty society guidelines. Am Heart J. 145:(1):2003;19-26
49. O'Brien T., Freemantle N., Osman A.D., Wolf F., Davis D.A., Herrin J. Continuing education meetings and workshops: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev. (2):2001;D003030
50. Hobbs F.D.R., Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: The Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract. 19:(6):2002;596-604
51. Frankel H.L., FitzPatrick M.K., Gaskell S., Hoff W.S., Rotondo M.F., Schwab C.W. Strategies to improve compliance with evidence-based clinical management guideline. J Am Coll Surg. 189:1999;533-538
52. Lanier D.C., Roland M., Burstin H., Knottnerus J.A. Doctor performance and public accountability. Lancet. 362:(9393):2003;1404-1408
53. Coomarasamy A., Ola B., Gee H. UK Royal College of Obstetricians and Gynaecologists. J Obstet Gynaecol. 23:(5):2003;479-483
54. Silagy C.A., Stead L.F., Lancaster T. Use of systematic reviews in clinical practice guidelines: case study of smoking cessation. BMJ. 323:2001;833-836
55. Collier J., Picton C., Littlejohns P. Coordinating locally 'owned' treatment guidelines. J R Coll Physicians Lond. 28:(6):1994;519-522
56. National Institute for Clinical Excellence (NICE): The Guideline Development Process: Information for Stakeholders. London, UK: Oaktree Press. 2001. Accessed October 27, 2003 at www.nice.org.uk
57. Academy of Managed Care Pharmacy (AMCP): Format for Formulary Submissions, Version 2.0. 2002. Accessed October 27, 2003 at http://www.fmcpnet.org/data/resource/formatv20.pdf
58. Shekelle P.G., Oritz E., Morton S.C., Eccles M.P., Martin E., Grinshaw J., et al. Validity of the agency for healthcare research and quality clinical practice guidelines: how quickly do guidelines become outdated? J Am Med Assoc. 286:(12):2001;1461-1467